Cite
HARVARD Citation
Rubio, G. et al. (2021). Cost-effectiveness of a cardiovascular polypill strategy (aspirin, atorvastatin, ramipril) for the secondary prevention of cardiovascular disease based on real life improvement in risk factor control. European journal of preventive cardiology. p. . [Online].